Live news related to ABIVAX stock (FR0012333284): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
ABIVAX continues its upward trend following positive announcements earlier in the week. At the close of Monday, November 10, the biotech's stock rose …
Abivax has released the results of its phase 3 trials on Obefazimod, showing notable improvements in patients with ulcerative colitis.
Abivax sees an uptick towards the end of the trading session on Tuesday, November 4. After a sharp decline of -8.36% on Monday, November 3, which mark…
Abivax experienced a significant correction at the close of trading on Monday, with shares ending the day below 83.30 euros. This decline is in stark …
ABIVAX stood out with one of the strongest weekly gains in the Parisian market, showing notable progress while the main French stock indices trended d…
Biotech company Abivax has entered the latter half of the week in positive territory. The stock is up 2.45% this Wednesday, reaching a price of 83.70 …
ABIVAX shares ended higher this Monday, October 27, gaining 3.03% to close at €81.60. The stock recorded the strongest performance in the SBF 120 at t…
Abivax shares closed higher on Thursday, October 23, gaining 4.2% to 79.30 euros. This rebound follows a week of decline, where the stock fell by 4.23…
The biopharmaceutical company Abivax ended the session on October 22 at 76.10 euros, down 4.4% from the previous day's close of 79.60 euros. This decl…
